GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
发明人:
申请号：
IL25650017
公开号：
IL256500A
申请日:
2017.12.22
申请国别(地区):
IL
年份:
2018
代理人:
摘要：
Disclosed is a compound which is or a tautomer thereof or a salt thereof, pharmaceutical compositions comprising said compound or a tautomer thereof or a pharmaceutically acceptable salt thereof, and the use in the treatment of diseases/disorders which are likely to be regulated at least in part by programmed necrosis, apoptosis or the production of inflammatory cytokines.
